Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progestogen-induced diabetes in the dog.

J M Sloan, I M Oliver

    Diabetes
    |April 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Indolent infections in patients with hematologic malignancy: A single-center experience screening for tuberculosis and strongyloidiasis prior to cytotoxic therapy in Boston.

    Leukemia research reports·2024
    Same author

    Neuralgic amyotrophy following high-dose melphalan and autologous peripheral blood stem cell transplantation for AL amyloidosis.

    Bone marrow transplantation·2017
    Same author

    The incidence of atrial fibrillation among patients with AL amyloidosis undergoing high-dose melphalan and stem cell transplantation: experience at a single institution.

    Bone marrow transplantation·2017
    Same author

    Effect of severe hypoalbuminemia on toxicity of high-dose melphalan and autologous stem cell transplantation in patients with AL amyloidosis.

    Bone marrow transplantation·2016
    Same author

    Hospital admissions following outpatient administration of high-dose melphalan and autologous SCT for AL amyloidosis.

    Bone marrow transplantation·2014
    Same author

    Safety and efficacy of high-dose melphalan and auto-SCT in patients with AL amyloidosis and cardiac involvement.

    Bone marrow transplantation·2013

    This study examines how high doses of synthetic hormones can trigger diabetes in female dogs. Researchers observed changes in blood sugar and insulin levels, alongside long-term damage to organs like the eyes and kidneys that resembles human diabetic complications. The findings suggest that dogs may serve as a valuable model for understanding how chronic diabetes affects the body over time.

    Area of Science:

    • Endocrinology and metabolism research within veterinary medicine
    • Progestogen-induced diabetes pathology in canine models

    Background:

    No prior work had resolved the specific long-term physiological consequences of synthetic hormone administration in canine models. It was already known that hormonal therapies can influence metabolic regulation in various mammalian species. That uncertainty drove researchers to investigate the link between high-dose progestogen and chronic metabolic dysfunction. Prior research has shown that exogenous hormones often disrupt glucose homeostasis in susceptible subjects. This gap motivated a detailed examination of how prolonged exposure leads to systemic health declines. Scientists have long sought reliable animal models to replicate the progression of human endocrine disorders. That historical context highlights why identifying specific triggers for canine diabetes remains a priority for veterinary science. The current investigation addresses these historical questions by documenting the emergence of diabetic symptoms in a controlled cohort.

    Purpose Of The Study:

    The aim of this study is to characterize the development of diabetes following prolonged high-dose synthetic progestogen administration. Researchers sought to document the physiological progression of this condition in a canine model. This investigation addresses the need for better understanding how exogenous hormones influence long-term metabolic stability. The team focused on identifying the specific biochemical and structural changes that occur during disease induction. By tracking blood sugar and insulin responses, they aimed to map the trajectory of glucose intolerance. This work was motivated by the lack of detailed longitudinal data regarding hormone-induced metabolic disorders in dogs. The authors intended to evaluate whether these animals could serve as a representative model for human diabetic complications. They established this research framework to bridge the gap between acute hormonal exposure and chronic systemic pathology.

    Keywords:
    canine endocrinologymetabolic disease modelhormonal side effectsdiabetic complications

    Frequently Asked Questions

    The researchers propose that high doses of synthetic progestogen disrupt glucose metabolism. This leads to altered blood sugar and plasma insulin responses during oral glucose challenges, eventually resulting in the development of a diabetic state within the female beagle cohort.

    The study utilized female beagles as the experimental subjects. These animals received large doses of synthetic progestogen over a one-year duration to facilitate the induction of the metabolic condition.

    Histological examination of the kidney and retina revealed lesions. These structural changes are comparable to the early signs of human diabetic nephropathy and retinopathy, demonstrating the relevance of the canine model for human disease.

    Plasma insulin and blood sugar measurements provided the necessary data. These metrics were tracked during oral glucose tolerance tests to characterize the metabolic shifts occurring throughout the induction phase.

    Related Experiment Videos

    Main Methods:

    The review approach involved monitoring a cohort of female beagles over a multi-year timeline. Investigators administered substantial quantities of synthetic hormones to induce metabolic changes. They performed serial assessments of blood sugar levels to track the onset of hyperglycemia. Plasma insulin responses were quantified following oral glucose administration to evaluate pancreatic function. After two years of persistent disease, the team conducted detailed histological evaluations of multiple organ systems. This systematic process allowed for the identification of structural damage in various tissues. The researchers compared these observed lesions against established markers of human diabetic complications. This methodology ensured a comprehensive analysis of both systemic metabolic shifts and localized tissue degradation.

    Main Results:

    Key findings from the literature indicate that high-dose synthetic hormone treatment successfully induced diabetes in the female beagle group. The subjects exhibited significant abnormalities in blood sugar regulation and plasma insulin responses during glucose testing. Histological analysis performed after two years revealed clear lesions within the renal and ocular tissues. These specific findings mirror the early-stage damage observed in human diabetic nephropathy and retinopathy. Furthermore, the researchers identified distinct structural changes within the pancreas and pituitary gland. The data demonstrate that these animals sustained chronic metabolic stress throughout the study duration. These results confirm the development of systemic complications following the initial induction phase. The evidence highlights a consistent pattern of organ damage linked to the prolonged diabetic state.

    Conclusions:

    The authors propose that the canine model effectively mimics key aspects of human diabetic pathology. Synthesis and implications suggest that long-term hormonal exposure leads to significant systemic damage. Observations of renal and ocular tissues indicate that these animals develop complications comparable to human patients. The researchers emphasize that the pancreas and pituitary gland undergo distinct structural alterations during the disease process. This evidence supports the utility of this species for studying chronic metabolic disease progression. The team highlights the value of these findings for future investigations into diabetic complications. Their work provides a foundation for understanding how persistent hyperglycemia impacts organ health over time. These results confirm that the dog remains a relevant subject for exploring the mechanisms underlying secondary diabetic conditions.

    The researchers observed structural damage in the pancreas and pituitary gland. These specific organ changes were identified through histological analysis performed after the subjects had lived with the condition for two years.

    The authors propose that the dog is a useful species for long-term pathology research. They suggest this model allows for the investigation of chronic complications that are otherwise difficult to observe in shorter-term studies.